O2 chief executive Ronan Dunne is exploring a debt-fuelled £8.5bn management buyout attempt following the collapse of CK Hutchison’s takeover bid for the mobile operator, The Daily Telegraph can reveal.
The Irishman, 52, has been approached in recent weeks by potential private equity sponsors aiming to carry out what would be the largest UK leveraged buyout since before the financial crisis. Executives at O2’s Berkshire headquarters are running the numbers to weigh whether it would be feasible for Mr Dunne, who has led O2 for eight years and previously served as its chief financial officer, to take it independent, sources said.
The discussions, which are in their early stages after the European Commission confirmed last week that it would not allow Hutchison to merge its own UK mobile operator, Three, with O2, are understood to not involve O2’s parent company, Telefonica. The Spanish giant remains bound by an exclusivity agreement with Hutchison until the end of next month unless the two sides agree to walk away sooner.
Investment bankers working with potential sponsors have pegged O2’s valuation in a leveraged buyout at £8.5bn, short of the £10.25bn that Hutchison was willing to pay, because of the savings it would have made by merging two networks.
Full Content: Telegraph
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas